MedPal AI Statistics
Total Valuation
MedPal AI has a market cap or net worth of GBP 26.49 million. The enterprise value is 27.23 million.
| Market Cap | 26.49M |
| Enterprise Value | 27.23M |
Important Dates
The next estimated earnings date is Wednesday, August 26, 2026.
| Earnings Date | Aug 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MedPal AI has 616.04 million shares outstanding. The number of shares has increased by 687.60% in one year.
| Current Share Class | 616.04M |
| Shares Outstanding | 616.04M |
| Shares Change (YoY) | +687.60% |
| Shares Change (QoQ) | +39.77% |
| Owned by Insiders (%) | 34.98% |
| Owned by Institutions (%) | 21.10% |
| Float | 390.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 16.52 |
| PB Ratio | 51.44 |
| P/TBV Ratio | 116.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 16.98 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.04, with a Debt / Equity ratio of 1.45.
| Current Ratio | 1.04 |
| Quick Ratio | 0.21 |
| Debt / Equity | 1.45 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.17 |
| Interest Coverage | -165.34 |
Financial Efficiency
Return on equity (ROE) is -4,337.54% and return on invested capital (ROIC) is -631.10%.
| Return on Equity (ROE) | -4,337.54% |
| Return on Assets (ROA) | -272.16% |
| Return on Invested Capital (ROIC) | -631.10% |
| Return on Capital Employed (ROCE) | -606.21% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 320,789 |
| Profits Per Employee | -1.42M |
| Employee Count | 5 |
| Asset Turnover | 1.29 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -183,184 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 2.75 |
| 200-Day Moving Average | 5.57 |
| Relative Strength Index (RSI) | 75.75 |
| Average Volume (20 Days) | 9,769,753 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MedPal AI had revenue of GBP 1.60 million and -7.10 million in losses. Loss per share was -0.02.
| Revenue | 1.60M |
| Gross Profit | 368,550 |
| Operating Income | -5.41M |
| Pretax Income | -7.28M |
| Net Income | -7.10M |
| EBITDA | n/a |
| EBIT | -5.41M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 4,189 in cash and 744,404 in debt, with a net cash position of -740,215 or -0.00 per share.
| Cash & Cash Equivalents | 4,189 |
| Total Debt | 744,404 |
| Net Cash | -740,215 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | 514,954 |
| Book Value Per Share | 0.00 |
| Working Capital | 52,123 |
Cash Flow
In the last 12 months, operating cash flow was -4.30 million and capital expenditures -153,410, giving a free cash flow of -4.45 million.
| Operating Cash Flow | -4.30M |
| Capital Expenditures | -153,410 |
| Depreciation & Amortization | 57,879 |
| Net Borrowing | 52,408 |
| Free Cash Flow | -4.45M |
| FCF Per Share | -0.01 |
Margins
| Gross Margin | 22.98% |
| Operating Margin | -337.37% |
| Pretax Margin | -454.11% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MedPal AI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -687.60% |
| Shareholder Yield | -687.60% |
| Earnings Yield | -26.80% |
| FCF Yield | -16.81% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MedPal AI has an Altman Z-Score of -1.38 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.38 |
| Piotroski F-Score | 1 |